Kidney organoids designed with the same mutation as that present in Fabry disease can help investigators better understand how the disease functions, authors suggested. A new report makes the case ...

Fabry disease (MIM 301500) is a genetic disorder resulting from the deficient activity of lysosomal hydrolase α-galactosidase (GLA; EC 3. 2.1.22). 1 The enzymatic defect causes the progressive ...

Fabry disease is a metabolic disease characterized by a deficiency in the lysosomal α-galactosidase enzyme caused by mutations in the GLA gene. This leads to substrate accumulation in the lysosomes, ...

Fabry disease runs in families. It can have lots of different symptoms, including pain in the hands and feet and a specific kind of rash. When you have Fabry disease, a certain type of fatty substance ...

Induced pluripotent stem (iPS) cells have a great impact on biology and medicine, and they are expected to improve regenerative medicine. Since 2014 when a sheet of retinal pigment epithelial cells ...

Fabry disease is a rare X-linked lysosomal storage disorder where a deficiency in α-galactosidase A (GLA) results in the pathological accumulation of globotriaosylceramide (Gb3 or GL-3) and other ...

From eating smaller meals to bypassing certain foods, these dietary changes can protect gut health and decrease symptoms for people living with Fabry disease. Fabry disease is a rare genetic disorder.

Fabry disease is an inherited genetic disorder in which people don’t have enough of an enzyme needed to break down a lipid (fatty substance), known as globotriaosylceramide (Gb3), in the body’s cells.

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #2 is a biotech by the name of Sangamo Therapeutics (SGMO). The reason why I believe it is important to ...